Assisted Walking Device Market To Reach $2 Billion By 2024



The global assisted walking device market is expected to reach over USD 2.0 billion by 2024 according to a new report by Grand View Research, Inc. The high market growth is anticipated onaccount of the steep rise in the geriatric population, high prevalence of chronic conditions, such as arthritis, Parkinson’s disease, conversion disorder, tendonitis, and the surging demand for rehabilitation equipment succeeding surgeries.

With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.

Furthermore, apart from the initiatives commenced by the government and private institutions to encourage the use of these assistive walking aids to mobilize the physically-challenged, the technology-oriented innovationsare transforming the current assisted devices,which are expected toserve as catalystsfor the market growthover the forecast period.
According to the estimates published by the WHO, the elderly population will rise from 900 million to 2.0 billion between 2015 and 2050.The demand for the walking devices is rising amongst thegeriatric population due mainlyto benefits, such as the provision of support, balance, and the subsequent ability to live independently. Moreover, the demand for the rehabilitation equipment is rising as a consequence of thesignificant role they play in bettering the lives of the physically-challenged.

With the aging population on the rise, the global incidences of arthritis are also escalating in accordance. The estimate stated by the centers of disease control and prevention indicatesthat by 2040, 78 million people will be suffering from arthritis in the U.S.There are over 232 million surgeries performed per year, whichreflects the high demand for the assistive walking devices as a part of the post-surgery rehabilitation programs.
The key players are actively participating in the development of novel walking devices that will create a considerable impact on the quality and durability of the devices thereby influencing market growth.The government organizations and private institutions implement various laws and policies for theassisted devices commercially available to the physicallydisabled people in order to increase their accessibility. Varied government-led programs are specifically directed toward financially assisting individuals in purchasing mobility aids in several countries, such as India, Canada, and Australia. 
To Request Sample Copy of this report, click the link:
A few key players in this market include Carex Health Brands, Inc., Invacare Corporation, Drive medical design and manufacturing, Inc., Sunrise Medical Laboratories, Inc., Electric mobility Euro Ltd., Pride Mobility Products Corporation, Briggs Healthcare Corporation, Graham-FieldHealth Products, Inc., Nova medical products, and Patterson Medical Holdings, Inc. The market dynamics provide a competitive platform for various players to tap into the high growth areas and cater to the high-unmet needs across the different regions. The established players are consistently engaged in launching modifications and new product designs to sustain a competitive advantage in the industry.
Further key findings from the study suggest:
·         In 2015, walkers accounted for the highest revenue share of 31.65%. The advantages related to the use of walkers over other walking devices, which include the improved ability to walk independently and safely, decreased pain and discomfort while walking, and the provision of wider support as compared to in other walking devices, and the high weight bearing capacity serve as major reasons resulting in the sizeable revenue share.
·         The demand is further accentuated due to the incorporation of these walkers in rehabilitation programs that aim to enable physical activityamongst the disabled, rebuilding of muscular strength, and to help attain optimal mobility of muscles.
·         The crutches segment is expected to emerge as the fastest growing segment with a CAGR of 10.3% over the forecast period.This rapid growth pace is a result of the high global demand for the crutches as supportive walking devices and as equipment employed to provide rehabilitative care.The crutches minimize the weight-bearing effect on the disabled leg and help improve the balance and stability of the individual while walking.
·         In 2015, North America dominated the Assisted Walking Device Market with a revenue share of 39.58% owing to the hike in thegeriatric population, presence of well-developed social and healthcare sectors, technological advancements forwarded by the leadingplayers in this region, and various initiatives commencedby the government and private organizations offering varied supportive servicesfor the benefit of the physically disabled people.
·         The Asia Pacific region is anticipated to grow at the maximum CAGR of over 10.7% from the year 2016 to 2024.Increasing public and private healthcare expenditure and the rising disposable incomes of the population are the key factors supporting the growth of the Assisted Walking Device Market in this region over the forecast period.
·         The market dynamics indicate the presence of strong competition amongst the key players, such as Carex Health Brands, Inc., Invacare Corporation, Drive medical design and manufacturing, Inc., Sunrise Medical Laboratories, Inc., Electric mobility Euro Ltd., Pride Mobility Products Corporation, Briggs Healthcare Corporation, Graham-Field Health Products, Inc., Nova medical products, and Patterson Medical Holdings, Inc.
The global Assisted Walking Device Market was valued at USD 803.0 million in 2015. Key factors accruing to the growth are the overwhelming geriatric population figures, rise in prevalence of target diseases, such as arthritis, and Parkinson’s disease, rise in the total number of surgical operations, globally, and financial support initiatives undertaken by government and private organizations to encourage the use of assistive mobility aids.
According to estimates published by the United Nations in 2012, the global geriatric population count was estimated to be nearly 809.4 million and is anticipated to reach an estimated figure of nearly 1.13 billion and 2 billion by 2022 and 2050, respectively. The chronic conditions prevalent among the elderly population have a detrimental impact on their musculoskeletal and neurological systems that further engenders walking disabilities in this population.
The increased prevalence of target diseases including Rheumatoid Arthritis and Parkinson’s disease is expected to propel the usage rates of the assisted walking devices over the forecast period. Rise in the total number of surgical operations creates a high demand for the assisted walking devices as they are employed in rehabilitation programs to gradually restore body balance and promote muscle functioning in sedentary, handicapped individuals. According to the data published by Healthcare Cost and Utilization Project (H-CUP), from 1992 – 2012, the rise in the total number of surgical operations was 17%.
Have any Query? Ask our Experts:
Grand View Research has segmented the Assisted Walking Device Market by product: 
Assisted Walking Device Market, by product (USD Million, 2016 - 2024)
·         Canes
·         Crutches
·         Walkers
·         Gait trainers
Initiatives hosted by government and private organizations provide access to equipment demonstrations at centers that furnish patients with relevant advice related to making an equipment choice suited to a specific disability. Additionally, patients with chronic illnesses or a long-standing disability are exempted from paying VAT on mobility products. The governments of the countries, the U.S. and the U.K. offer special grants to the physically-handicapped patients to purchase this equipment. Independent organizations including Charity search, Disablement Information and Advice Lines (DIAL) network, Rica, and Shop mobility are actively engaged in providing varied services for the physically disabled seeking solutions. The WHO has declared the Priority Assistive Products List, which has been published with the objective of promoting equitable access of assistive mobility aids to those in need, and further, the list serves to outline reimbursement policies and to provide guidance in matters related to purchase of these devices.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.





Comments

Popular posts from this blog

Vertical Farming Market Growth On The Basis Of Type, Application, Region & Forecast To 2030: Grand View Research Inc.

Clinical Diagnostics Market Segment Analysis By Size, Share & Trends Analysis Report By Application, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2025

Satellite Payload Market Growth On The Basis Of Type, Application, Region & Forecast To 2025: Grand View Research Inc.